Related Experiment Video
Updated: Sep 27, 2025

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
Published on: August 18, 2020
Psychosis and substance abuse increase the COVID-19 mortality risk
Ana Catalan1,2,3,4, Claudia Aymerich1, Amaia Bilbao5,6,7
1Osakidetza Basque Health Service, Department of Psychiatry, Basurto University Hospital, Bilbao, Spain.
Insights
Patients with psychotic disorders faced higher COVID-19 mortality and hospitalization rates. Affective disorders were associated with lower mortality during the pandemic.
Area of Science:
- Epidemiology
- Public Health
- Psychiatry
Background:
- The coronavirus disease 2019 (COVID-19) pandemic posed significant global health challenges.
- Elevated mortality rates were observed in specific risk groups, notably individuals with pre-existing mental health conditions.
Purpose of the Study:
- To investigate the association between pre-existing mental disorders and COVID-19 outcomes.
- To determine factors influencing COVID-19-related mortality and hospital admission rates in a defined population.
Main Methods:
- Retrospective analysis of electronic health records from March 2020 to March 2021 in the Basque Country.
- COVID-19 cases identified via positive reverse transcription-polymerase chain reaction (PCR) tests.
- Statistical analysis using logistic regression and multilevel models to assess mortality and hospitalization risk factors.
Main Results:
- Increased COVID-19 mortality rates were observed in patients with psychotic disorders (adjusted OR: 1.45) and substance abuse (adjusted OR: 1.88).
- Patients with affective disorders showed a decreased mortality rate (adjusted OR: 0.80).
- Higher hospital admission rates for COVID-19 were noted in psychosis (adjusted OR: 2.90) and anxiety disorder groups (adjusted OR: 1.54).
Conclusions:
- Pre-existing psychotic disorders were linked to increased COVID-19 mortality and hospitalization rates.
- Affective disorders were associated with a decreased mortality rate among hospitalized COVID-19 patients.
Background:
The coronavirus disease 2019 (COVID-19) pandemic has been a global challenge. High mortality rates have been reported in some risk groups, including patients with pre-existing mental disorders.
Methods:
We used electronic health records to retrospectively identify people infected due to COVID-19 (between March 2020 and March 2021) in the three territories of the Basque Country. COVID-19 cases were defined as individuals who had tested positive on a reverse transcription-polymerase chain reaction (PCR) test. Univariate and multivariate logistic regression models and multilevel analyses with generalized estimated equations were used to determine factors associated with COVID-19-related mortality and hospital admission.
Results:
The COVID-19 mortality rate was increased for patients with psychotic disorders [odds ratio (OR) adjusted: 1.45, 95% confidence interval (CI) (1.09-1.94), p = 0.0114] and patients with substance abuse [OR adjusted: 1.88, 95% CI (1.13-3.14, p < 0.0152)]. The mortality rate was lower for patients with affective disorders [OR adjusted: 0.80, 95% CI (0.61-0.99), p = 0.0407]. Hospital admission rates due to COVID-19 were higher in psychosis [OR adjusted: 2.90, 95% CI (2.36-3.56), p < 0.0001] and anxiety disorder groups [OR adjusted: 1.54, 95% CI (1.37-1.72), p < 0.0001]. Among admitted patients, COVID-19 mortality rate was decreased for those with affective disorders rate [OR adjusted: 0.72, 95% CI (0.55-0.95), p = 0.0194].
Conclusions:
COVID-19-related mortality and hospitalizations rates were higher for patients with a pre-existing psychotic disorder.
More Related Videos
07:31Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
09:29Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
Related Concept Videos
Stress and Mental Health
Individuals with depression often experience challenges in both their personal and professional...
Psychological and Sociocultural Causes of Schizophrenia
Psychosis and Antipsychotic Drugs: Overview
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Psychosis: Goals of Pharmacotherapy
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...